| [1] |
LI Jiawei, GAO Xinyi, GE Aoqi, LI Juanjuan, YUAN Beibei.
Demand and Associated Factors for Integrated Medical Care and Preventive Services among Patients with Type 2 Diabetes
[J]. Chinese General Practice, 2026, 29(21): 3028-3039.
|
| [2] |
ZHOU Xiaoya, WANG Weikai, LIU Qian, LI Jianhua, SUN Bo, WANG Yanxia.
Study of the Interaction between Sleep Quality and Melatonin Receptor 1B Gene Polymorphism on Gestational Hypertension
[J]. Chinese General Practice, 2026, 29(21): 2975-2981.
|
| [3] |
AN Yanhong, WANG Shidong, LI Xiaoran, GUO Jiayang, WANG Zhe, SHA Peilin, MENG Yijun, LI Xiaoxuan, SHI Xue, YU Zexing, XIAO Yonghua.
Study on Risk Factors and Nomogram Prediction Model for Diabetic Kidney Disease: Based on Contrast-enhanced Ultrasound Technology
[J]. Chinese General Practice, 2026, 29(21): 2995-3003.
|
| [4] |
PAN Ziyun, YIN Hao, LIN Zhirou, MAO Jingyi, HUANG Yan, LUO Yanhua, XIAO Jiafu, HU Yin.
From Mechanism to Therapy: Diabetic Autonomic Neuropathy
[J]. Chinese General Practice, 2026, 29(21): 2982-2988.
|
| [5] |
YU Haiyan, XIANG Tong, GAO Wenjuan, WU Hao.
Research and Application of Digital Health Technologies in Multimorbidity Management
[J]. Chinese General Practice, 2026, 29(21): 2933-2937.
|
| [6] |
WANG Yang, ZHAO Shiting, CHEN Yingying, SUN Zilin, QIU Shanhu.
Key Points of Exercise Intervention and Implementation for People with Complications of Type 2 Diabetes Mellitus
[J]. Chinese General Practice, 2026, 29(21): 2989-2994.
|
| [7] |
REYILAI· Maimaiti, ZHOU Yiran, WU Yun, LIU Zhencheng, LU Yaoqin, WU Haiyan.
Association between Novel Obesity Indicators and Cardiovascular Disease Risk in Hypertensive Patients
[J]. Chinese General Practice, 2026, 29(20): 2836-2845.
|
| [8] |
CHENG Yu, HAN Shiyao, SUN Ping, XIANG Juan, YANG Hui, LI Dongze, ZHENG Li, LIAO Xiaoyang.
Analysis of Socioeconomic and Demographic Challenges in Chronic Disease Management
[J]. Chinese General Practice, 2026, 29(20): 2800-2807.
|
| [9] |
GE Dan, WANG Zhi, DING Qun, GUO Tonglan, XU Tongdao.
Relationship between Remnant Cholesterol and Non-alcoholic Fatty Liver Disease as well as Progressive Liver Fibrosis in Patients with Type 2 Diabetes Mellitus
[J]. Chinese General Practice, 2026, 29(20): 2854-2859.
|
| [10] |
ZHANG Xiaojuan, LIU Yang, PENG Bo, YE Yuan, ZHU Kun.
Study on the Prevention and Treatment of Hypertension and Diabetes Mellitus in Community Hospital
[J]. Chinese General Practice, 2026, 29(19): 2614-2620.
|
| [11] |
LIU Daiyue, LIU Xincan, LAN Zhenzhen.
Research Progress on Postprandial Hyperlipidemia and Its Therapeutic Approaches
[J]. Chinese General Practice, 2026, 29(18): 2546-2553.
|
| [12] |
JIAN Yingchun, ZENG Yongqin, ZHANG Haiping, WANG Zhengdi, AN Ke, YAN Rui.
Recent Advances in Mitochondrial Dysfunction in Chronic Metabolic Diseases
[J]. Chinese General Practice, 2026, 29(18): 2577-2584.
|
| [13] |
MIAO Jingjie, ZHANG Jinwen, WU Qianhao, HAN Peipei.
Research Advances on the Effects of Intermittent Fasting on Cardiometabolic Diseases
[J]. Chinese General Practice, 2026, 29(18): 2538-2545.
|
| [14] |
CHEN Qiulong, CHEN Jia, FANG Jing, DAI Wei, YANG Qing.
Application Status and Research Progress of Observer-reported Outcome
[J]. Chinese General Practice, 2026, 29(18): 2561-2570.
|
| [15] |
LI Yachan, YANG Yang, XU Qianting, KE Tingyu.
Association between the Chinese Visceral Adiposity Index and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus
[J]. Chinese General Practice, 2026, 29(18): 2482-2488.
|